Yahoo Finance

Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study

TORONTO, April 10, 2024 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and ...
Digital Journal

Avicanna and Santé Cannabis Initiate Real-World Evidence Study on Musculoskeletal Pain and Inflammation with the RHO Phyto™ CBG Transdermal Gel Topical Product

The research study will seek to enroll 100 patients and evaluate patient-reported efficacy of the RHO Phyto CBG Transdermal Gel containing 2% Cannabidiol (“CBD”) and 1% CBG on arthritis including ...
Nasdaq

Avicanna completes first delivery of topical products to pharmaceutical company

Avicanna (AVCNF) announced the initial delivery of its proprietary topical products into Europe as a part of the previously announced exclusive supply agreement with a multinational pharmaceutical ...
Mena FN

Avicanna Announces Completion Of Topical Gel Observational Real-World Evidence Study

(MENAFN- GlobeNewsWire - Nasdaq) The study results revealed improvements in symptoms and quality of life in patients with musculoskeletal pain and inflammation TORONTO, April 10, 2024 (GLOBE NEWSWIRE) ...
Proactive Investors

Avicanna and Santé Cannabis initiate real-world evidence study with RHO Phyto CBG Transdermal Gel

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return ...